tykhr
sign in
free sign up
ACADIA Pharmaceuticals Inc
Biotechnology
Healthcare
ACAD
166 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
22.38
52 week high
22.95
high
23.04
52 week low
14.10
low
22.16
growth
37.87 %
previous Close
22.41
P/E ratio
market cap
2.86 B
div yield
0
usd
Sep 2024
qoq
revenue
250 M
3.49 %
net incoming
32.77 M
-1.87 %
eps
0.00 %
0.00 %
eps surprise
42.86 %
net profit margin
13.09 %
0.00 %
operating incoming
31.64 M
3.97 %
net change in cash
-13.22 M
52.14 %
cash on hand
155 M
-12.41 %
cost of revenue
18.86 M
3.44 %
top